Search Results - "Nasr, Fady"

Refine Results
  1. 1

    Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study by Hajj, Aline, Hachem, Roula, Khoury, Rita, Hallit, Souheil, Eiebbawi, Bashar, Nasr, Fady, El Karak, Fadi, Chahine, Georges, Kattan, Joseph, Rabbaa Khabbaz, Lydia

    Published in BMC cancer (30-07-2021)
    “…Background Despite the progress in assessment and treatment of breast cancer, being diagnosed with it or receiving chemotherapy treatment is still conceived as…”
    Get full text
    Journal Article
  2. 2

    Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the “CAGE-Cog” study by Hajj, Aline, Khoury, Rita, Hachem, Roula, Awad, Aya, Hallit, Souheil, Sacre, Hala, Nasr, Fady, Karak, Fadi El, Chahine, Georges, Kattan, Joseph, Khabbaz, Lydia Rabbaa

    Published in BMC cancer (19-09-2022)
    “…Background Breast cancer patients undergoing chemotherapy treatment are at particular risk of experiencing acute cognitive impairment leading to daily…”
    Get full text
    Journal Article
  3. 3

    Management of Multiple Myeloma in the Middle East: Unmet Needs, Challenges and Perspective by Ibrahim, Ahmad, Chamseddine, Nabil, El-cheikh, Jean, Hanna, Colette, Moukadem, Walid, Nasr, Fady, Younis, Ahmad, Bazarbachi, Ali

    Published in Clinical hematology international (01-12-2022)
    “…Multiple myeloma (MM) is a prevalent hematological malignancy. Resource-constrained settings such as the Middle East are particularly burdened by the…”
    Get full text
    Journal Article
  4. 4

    Bellini duct carcinoma : two case reports by Makhoul, Rita, Maddah, Janah, Jabbur, Rami, Nasr, Fadi, Muqbil, Elias

    Published in Maġallat al-ṭibbiyat al-lubnāniyyat (01-10-2014)
    “…We report two rare cases of Bellini duct carcinoma, a rare variant of renal cell carcinoma. Case 1: The patient, a 73-year-old female, was admitted to the…”
    Get full text
    Journal Article
  5. 5

    Adjuvant chemo-radiation for gastric adenocarcinoma: an institutional experience by Aftimos, Philippe G, Nasr, Elie A, Nasr, Dolly I, Noun, Roger J, Nasr, Fady L, Ghosn, Marwan G, El Helou, Joelle A, Chahine, Georges Y

    Published in Radiation oncology (London, England) (04-06-2010)
    “…Studies have shown that surgery alone is less than satisfactory in the management of early gastric cancer, with cure rates approaching 40%. The role of…”
    Get full text
    Journal Article
  6. 6

    Les soins palliatifs au Liban : attitudes et défis expérience de notre équipe au sein d’un hôpital universitaire by al-Karak, Fadi, Hlais, Sani, Farah, Pamela, Haddad, Nadin Maluf, Tumah, Aline, Nasr, Fadi, Ghusn, Marwan, Qattan, Juzif, Mouhawej, Mari Claire

    “…Objectives : A palliative care consultation team, created in our university hospital, started in January 2014 to answer the request of consultation in the…”
    Get full text
    Journal Article
  7. 7

    Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC) by Kattan, Joseph G., Farhat, Fady S., Chahine, Georges Y., Nasr, Fady L., Moukadem, Walid T., Younes, Fariha C., Yazbeck, Nadine J., Ghosn, Marwan G.

    Published in Investigational new drugs (01-02-2008)
    “…Summary Treatment options for patients with hormone refractory prostate cancer (HRPC) showed unsatisfactory outcomes. Docetaxel-based combinations could offer…”
    Get full text
    Journal Article
  8. 8

    Gemcitabine plus Carboplatin Combination Therapy as Second-Line Treatment in Patients with Relapsed Breast Cancer by Nasr, Fady L., Chahine, George Y., Kattan, Joseph G., Farhat, Fadi S., Mokaddem, Walid T., Tueni, Elias A., Dagher, Joya E., Ghosn, Marwan G.

    Published in Clinical breast cancer (01-06-2004)
    “…This study was designed to determine the safety and efficacy of the combination therapy of gemcitabine plus carboplatin when used as a second-line treatment in…”
    Get full text
    Journal Article
  9. 9

    Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives by Ar, Muhlis Cem, El Fakih, Riad, Gabbassova, Saule, Alhuraiji, Ahmad, Nasr, Fady, Alsaeed, Ahmad, Sayinalp, Nilgun, Marashi, Mahmoud

    Published in Leukemia research (01-10-2023)
    “…Secondary immunodeficiency (SID) can occur as a result of multiple factors, including hematological malignancies, hematopoietic stem cell transplantation…”
    Get full text
    Journal Article
  10. 10

    Supplement use and its impact on daily life of cancer patients: a cross-sectional study by El Toum, Youssef, Costa, Tarek, El Toum, Elissa, Haddad, Tina, Salameh, Pascale, El karak, Fady, Ghosn, Marwan, Nasr, Fady, Chahine, Georges, Kattan, Joseph, Kourie, Hampig Raphael

    Published in Supportive care in cancer (01-03-2024)
    “…Purpose This cross-sectional study aimed to investigate the prevalence and characteristics of supplement usage among cancer patients and explore its potential…”
    Get full text
    Journal Article
  11. 11

    Clinical and Genetic Factors Associated With the Breast Cancer-Related Sleep Disorders: The “CAGE-Sleep” Study–A Cross-Sectional Study by Hajj, Aline, Hachem, Roula, Khoury, Rita, Nehme, Tamara, Hallit, Souheil, Nasr, Fady, Karak, Fady El, Chahine, Georges, Kattan, Joseph, Khabbaz, Lydia Rabbaa

    Published in Journal of pain and symptom management (01-09-2021)
    “…Despite being among the most reported concerns in breast cancer patients, sleep disturbances are still poorly assessed and managed in routine clinical…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Analysis of Survival of Patients with Chronic Myeloid Leukemia Treated with Imatinib in the Last 15 Years in Lebanon by Massoud, Marcel, Sakr, Riwa, Kerbage, Fouad, Makdissi, Joseph, Hawi, Jenny, Rached, Layale, Nasr, Fady, Chahine, Georges

    Published in Clinical lymphoma, myeloma and leukemia (01-07-2017)
    “…In the 2000s, the introduction of the tyrosine kinase inhibitor, imatinib, improved the survival outcomes of patients with chronic myeloid leukemia (CML). In…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Survival Pattern of Hodgkin Lymphoma Patients in the Last 25 Years in Lebanon by Massoud, Marcel, Kerbage, Fouad, Nehme, Joseph, Sakr, Riwa, Rached, Layale, Zeghondy, Jean, Nasr, Fady, Chahine, Georges

    Published in Clinical lymphoma, myeloma and leukemia (01-07-2017)
    “…We retrospectively compared the overall survival in HL over 3 different decades in Lebanon. Patients were divided into 3 groups according to period of…”
    Get full text
    Journal Article
  20. 20

    Lung cancer and immunotherapy: a real-life experience from second line and beyond by El Karak, Fady, Gh Haddad, Fady, Eid, Roland, Al Ghor, Maya, El Rassy, Elie, Ahmadieh, Nizar, Choullamy, Theresia, Halim, Nour A, Tfayli, Arafat, Farhat, Fadi, Kattan, Joseph, Nasr, Fady, Ghosn, Marwan, Assi, Hazem I

    Published in Future oncology (London, England) (01-09-2019)
    “…This study assessed the efficacy of anti-PD-1/PD-L1 agents in real life when used in second line or beyond. Patients with advanced non-small-cell lung cancer…”
    Get full text
    Journal Article